Apolipoproteins in the brain: implications for neurological and psychiatric disorders

被引:143
|
作者
Elliott, David A. [1 ]
Weickert, Cyndi Shannon [1 ,2 ,3 ]
Garner, Brett [1 ,4 ]
机构
[1] Prince Wales Med Res Inst, Sydney, NSW 2031, Australia
[2] Schizophrenia Res Inst, Sydney, NSW, Australia
[3] Univ New S Wales, Sch Psychiat, Fac Med, Sydney, NSW 2052, Australia
[4] Univ Wollongong, Sch Biol Sci, Fac Sci, Wollongong, NSW 2522, Australia
基金
澳大利亚研究理事会;
关键词
apolipoprotein; brain; CNS; lipid; neurological disease; AMYLOID-BETA-PEPTIDE; LOW-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; E MESSENGER-RNA; BINDING CASSETTE TRANSPORTERS; GREEN FLUORESCENT PROTEIN; GENOME-WIDE ASSOCIATION; E EPSILON-4 ALLELE; A-I GENE; ALZHEIMERS-DISEASE;
D O I
10.2217/CLP.10.37
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The brain is the most lipid-rich organ in the body and, owing to the impermeable nature of the blood brain barrier, lipid and lipoprotein metabolism within this organ is distinct from the rest of the body. Apolipoproteins play a well-established role in the transport and metabolism of lipids within the CNS; however, evidence is emerging that they also fulfill a number of functions that extend beyond lipid transport and are critical for healthy brain function. The importance of apolipoproteins in brain physiology is highlighted by genetic studies, where apolipoprotein gene polymorphisms have been identified as risk factors for several neurological diseases. Furthermore, the expression of brain apolipoproteins is significantly altered in several brain disorders. The purpose of this article is to provide an up-to-date assessment of the major apolipoproteins found in the brain (ApoE, ApoJ, ApoD and ApoA-I), covering their proposed roles and the factors influencing their level of expression. Particular emphasis is placed on associations with neurological and psychiatric disorders.
引用
收藏
页码:555 / 573
页数:19
相关论文
共 50 条
  • [1] Psychiatric Implications of Neurological Disorders
    Irfan, Muna
    [J]. PSYCHIATRIC ANNALS, 2017, 47 (05) : 224 - 225
  • [2] The social brain in psychiatric and neurological disorders
    Kennedy, Daniel P.
    Adolphs, Ralph
    [J]. TRENDS IN COGNITIVE SCIENCES, 2012, 16 (11) : 559 - 572
  • [3] The neuirobiology of Apolipoproteins in psychiatric disorders
    Thomas, EA
    Sutcliffe, JG
    [J]. MOLECULAR NEUROBIOLOGY, 2002, 26 (2-3) : 369 - 388
  • [4] The neurobiology of apolipoproteins in psychiatric disorders
    Elizabeth A. Thomas
    J. Gregor Sutcliffe
    [J]. Molecular Neurobiology, 2002, 26 : 369 - 388
  • [5] Deep brain stimulation in neurological and psychiatric disorders
    York, Michele K.
    Strutt, Adriana M.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2009, 31 (07) : 892 - 894
  • [6] Deep Brain Stimulation in Neurological and Psychiatric Disorders
    Coenen, Volker A.
    Amtage, Florian
    Volkmann, Jens
    Schlaepfer, Thomas E.
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (31-32): : 519 - U11
  • [7] Neuroplasticity; the mechanisms and implications for treatment of neurological and psychiatric disorders
    Lea, Hannah
    [J]. ARCHIVES OF CLINICAL PSYCHIATRY, 2022, 49 (04) : 1 - 9
  • [8] Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
    Olloquequi, Jordi
    Cornejo-Cordova, Elizabeth
    Verdaguer, Ester
    Soriano, Francesc X.
    Binvignat, Octavio
    Auladell, Carme
    Camins, Antoni
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (03) : 265 - 275
  • [9] Brain banking in neurological and psychiatric disorders - The Amsterdam experience
    Ravid, R
    Kamphorst, W
    [J]. ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 565 - 565
  • [10] Consent to Deep Brain Stimulation for Neurological and Psychiatric Disorders
    Glannon, Walter
    [J]. JOURNAL OF CLINICAL ETHICS, 2010, 21 (02): : 104 - 111